Acular and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Acular and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ketorolac ophthalmic
Brand name: Acular, Acular LS, Acuvail, Acular PF
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acular-Insulin glargine, recombinant Subcutaneous
- Acular-Insulin glulisine
- Acular-Insulin Glulisine (Cartridges and Pens)
- Acular-Insulin Glulisine (Vials)
- Acular-Insulin glulisine Subcutaneous
- Acular-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Acular eent
- Insulin glargine and lixisenatide Subcutaneous-Acular LS
- Insulin glargine and lixisenatide Subcutaneous-Acular PF
- Insulin glargine and lixisenatide Subcutaneous-Acunivive 15 Injection System
- Insulin glargine and lixisenatide Subcutaneous-Acunivive 30 Injection System
- Insulin glargine and lixisenatide Subcutaneous-Acunivive 60 Injection System